WO2002000005A8 - Libraries displaying human antibody fragments with hybrid complementarity determining regions - Google Patents
Libraries displaying human antibody fragments with hybrid complementarity determining regionsInfo
- Publication number
- WO2002000005A8 WO2002000005A8 PCT/US2001/019502 US0119502W WO0200005A8 WO 2002000005 A8 WO2002000005 A8 WO 2002000005A8 US 0119502 W US0119502 W US 0119502W WO 0200005 A8 WO0200005 A8 WO 0200005A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- determining regions
- hybrid
- antibody fragments
- human antibody
- complementarity determining
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001268545A AU2001268545A1 (en) | 2000-06-21 | 2001-06-18 | Libraries displaying human antibody fragments with hybrid complementarity determining regions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21319600P | 2000-06-21 | 2000-06-21 | |
US60/213,196 | 2000-06-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002000005A1 WO2002000005A1 (en) | 2002-01-03 |
WO2002000005A8 true WO2002000005A8 (en) | 2002-03-07 |
Family
ID=22794104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/019502 WO2002000005A1 (en) | 2000-06-21 | 2001-06-18 | Libraries displaying human antibody fragments with hybrid complementarity determining regions |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001268545A1 (en) |
WO (1) | WO2002000005A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7981843B2 (en) | 2004-01-20 | 2011-07-19 | Kalobios Pharmaceuticals, Inc. | Antibody specificity transfer using minimal essential binding determinants |
ES2429541T3 (en) | 2004-11-16 | 2013-11-15 | Kalobios Pharmaceuticals, Inc. | Immunoglobulin variable region cassette exchange |
JO2787B1 (en) | 2005-04-27 | 2014-03-15 | امجين إنك, | Substituted Amid derivatives & methods of use |
WO2015133882A1 (en) * | 2014-03-07 | 2015-09-11 | 사회복지법인 삼성생명공익재단 | Scfv antibody library, method for preparing same, and scfv antibody screening method using same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2136092T3 (en) * | 1991-09-23 | 1999-11-16 | Medical Res Council | PROCEDURES FOR THE PRODUCTION OF HUMANIZED ANTIBODIES. |
JP2001523958A (en) * | 1997-03-21 | 2001-11-27 | ブライハム アンド ウィミンズ ホスピタル,インコーポレイテッド | CTLA-4 binding peptides for immunotherapy |
US6160099A (en) * | 1998-11-24 | 2000-12-12 | Jonak; Zdenka Ludmila | Anti-human αv β3 and αv β5 antibodies |
-
2001
- 2001-06-18 WO PCT/US2001/019502 patent/WO2002000005A1/en active Application Filing
- 2001-06-18 AU AU2001268545A patent/AU2001268545A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002000005A1 (en) | 2002-01-03 |
AU2001268545A1 (en) | 2002-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003048321A3 (en) | Hybrid antibodies | |
WO2004041865A3 (en) | Stabilized single domain antibodies | |
WO1998050433A3 (en) | Human monoclonal antibodies to epidermal growth factor receptor | |
WO2004108889A3 (en) | Hybrid antibodies | |
HK1076128A1 (en) | Humanized collagen antibodies and related methods | |
WO2002020569A3 (en) | Mammalian genes; related reagents and methods | |
WO2006084075A3 (en) | Adam-9 modulators | |
WO2002084249A3 (en) | Therapeutic and diagnostic uses of antibody specificity profiles | |
WO2004001381A3 (en) | Novel raag10 cell surface target and a family of antibodies recognizing that target | |
WO2003004648A1 (en) | Anti_human ovarian cancer -anti_cd3 bispecific antibody | |
WO2006014498A3 (en) | Universal antibody libraries | |
NO20054351L (en) | Monoclonal antibody and hybridoma producing this | |
AU2002338015A1 (en) | Human CDR-grafted antibodies and antibody fragments thereof | |
CA2068222A1 (en) | Monoclonal antibodies | |
WO2004025248A3 (en) | Antibody pair screening methods | |
WO2003029458A3 (en) | Method for producing protein libraries and for selecting proteins from said libraries | |
EP2186884A3 (en) | HCV-anti-core monoclonal antibody | |
WO2004022717A3 (en) | Minimally immunogenic variants of humanized col-1 antibody against carcinoembryonic antigen | |
WO2003087340A3 (en) | Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof | |
WO2004099242A3 (en) | Streptococcus agalactiae antigens i + ii | |
WO2005028498A3 (en) | Kid3 and kid3 antibodies that bind thereto | |
WO2002094853A3 (en) | Antibodies specific for poly(ethylene glycol) | |
DK1167389T3 (en) | Antibodies to the SEMP1 protein, method of preparation thereof, and use thereof | |
WO2005051999A3 (en) | Substance binding human igg fc receptor iib | |
WO2002000005A8 (en) | Libraries displaying human antibody fragments with hybrid complementarity determining regions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 01/2002 UNDER (51) REPLACE "NOT CLASSIFIED" BY "G01N 33/53"; REPLACE "A2" BY "A1" AND UNDER "PUBLISHED", REPLACE "WITHOUT INTERNATIONAL SEARCH REPORT" BY "WITH INTERNATIONAL SEARCH REPORT" |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase in: |
Ref country code: JP |